COReMIND

Home / Programs / COReMIND

COGNITIVE OPTIMIZATION, ReVERSING MEMORY IMPAIRMENT & NEUROLOGIC DYSFUNCTION

WHAT IS COREMIND?

  • COReMIND brings a new paradigm to treating dementia, and is the first program to offer true hope for preventing and reversing the cognitive decline of Subjective Cognitive Impairment (SCI), Mild Cognitive Impairment (MCI) and early Alzheimer’s dementia.
  • COReMIND stands for Cognitive Optimization and Reversing Memory Impairment and Neurologic Dysfunction. It is a comprehensive, holistic, individualized, evidence-based method of preventing and reversing cognitive decline and dementia.

There are two phases to the COReMIND program: Assessment and Implementation

  • During the Assessment phase the patient will undergo a comprehensive series of evaluations including health questionnaires, physical exam, body composition analysis, cognitive testing via standardized computer-based evaluations, extensive lab evaluations consisting of blood, urine and saliva tests to determine the nutritional, metabolic, hormonal, environmental, and genetic factors that may be contributing to your illness, as well as vestibular testing through VNG (Video Nystagmography).
  • Based on results from your assessment, we will design and help implement a personalized program to address all the factors that may be contributing to your cognitive decline.
  • Treatment is based on intensive lifestyle therapy in addition to nutritional supplementation, medication, and hormone replacement therapy when medically indicated.
  • The team of professionals at P3 Health can offer all the necessary support to ensure your success.
  • Over the course of 12 months, we will monitor your progress, with repeat testing as needed, and continuously update your treatment plan, which will be modified based on your symptoms and test results.

WHY IS IT IMPORTANT TO YOU?

  • Dementia is a devastating illness that touches not only its sufferers, but their families as well. There are currently over 564,000 people with dementia in Canada and that number is expected to top 1 million in the next 15 years due to the large number of aging baby boomers. That means that almost 3% of the population will have dementia by 2033 if the current trends continue.
  • The current medical model for treating dementia is failing. Dementia is a complex, systemic illness that has proven resistant to all past and current trials of single drug therapy. We must move past this simplistic view of chronic disease, and recognize that waiting for the “magic pill” is getting us nowhere.

 

For more information, please contact P3 Health